Abstract
Background
Endophthalmitis is a potentially blinding intraocular infection following intraocular surgery or trauma. Prompt diagnosis and treatment are important in preventing devastating visual complications. Procalcitonin (PCT) is a promising biomarker for diagnosing bacterial infections. The aim of the study was to measure vitreous PCT in infectious endophthalmitis and assess its utility as a biomarker.
Methods
In this prospective study, vitreous was collected from patients with non-infectious retinal disorders and infectious endophthalmitis. PCT was measured using the Human Procalcitonin ELISA Kit. The diagnostic performance of PCT was calculated via receiver operating characteristic curves.
Results
The study included three groups: patients with non-infectious retinal conditions, culture-positive endophthalmitis, and culture-negative endophthalmitis. The average PCT was 75.74 ± 26.8 pg mL−1, 100.24 ± 12.9 pg mL−1, and 126.41 ± 26.47 pg mL−1 in control, culture-negative, and culture-positive endophthalmitis, respectively. There was a significant difference in the vitreous PCT in the study and control groups (p = 0.04), but not between culture-positive and culture-negative endophthalmitis (p = 0.65). The sensitivity (66.7%) and specificity (65%) for PCT with a cut-off of ≤ 54.88 pg mL−1(p = 0.31) implied that its diagnostic accuracy was not significant. But there was a significant difference in gram-negative (68.2 ± 16.5 pg mL−1) and gram-positive (175.09 ± 45 pg mL−1) (p = 0.02) bacterial infections; the sensitivity and specificity were 70%, with a cut-off of ≤ 82.3 pg mL−1.
Conclusions
This study showed that vitreous procalcitonin concentration might not be a suitable biomarker for diagnosing culture-negative endophthalmitis though it could help distinguish between gram-positive and gram-negative infections.
Similar content being viewed by others
References
Weber DJ, Hoffman KL, Thoft RA, Baker AS (1986) Endophthalmitis following intraocular lens implantation: report of 30 cases and review of the literature. Rev Infect Dis 8(1):12–20. https://doi.org/10.1093/clinids/8.1.12
Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN (1991) Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 98(5):639–649. https://doi.org/10.1016/s0161-6420(91)32239-5
Das T, Kunimoto DY, Sharma S, Jalali S, Majji AB, Nagaraja Rao T et al (2005) Endophthalmitis research group. Relationship between clinical presentation and visual outcome in postoperative and posttraumatic endophthalmitis in south central India. Indian J Ophthalmol. 53(1):5–16. https://doi.org/10.4103/0301-4738.15298
Naik P, Singh S, Dave VP, Ali MH, Kumar A, Joseph J (2020) Vitreous D-lactate levels as a biomarker in the diagnosis of presumed infectious culture negative endophthalmitis. Curr Eye Res 45(2):184–189. https://doi.org/10.1080/02713683.2019.1662057
SR, Gardner TW (2016) Diabetic retinopathy and diabetic macular edema. In: Nguyen QD, Rodrigues EB, Farah ME, Mieler WF, Do DV, editors. Retinal pharmacotherapeutics. Dev Ophthalmol. Basel: Karger 55: 137–46
Wacker C, Prkno A, Brunkhorst FM, Schlattmann P (2013) Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 13(5):426–435. https://doi.org/10.1016/S1473-3099(12)70323-7
BalcI C, Sungurtekin H, Gürses E, Sungurtekin U, Kaptanoglu B (2003) Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 7(1):85–90. https://doi.org/10.1186/cc1843
Tang BM, Eslick GD, Craig JC, McLean AS (2007) Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 7(3):210–217. https://doi.org/10.1016/S1473-3099(07)70052-X
Bernard L, Ferrière F, Casassus P, Malas F, Lévêque S, Guillevin L et al (1998) Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis 27(4):914–915. https://doi.org/10.1086/517175
Blijlevens NM, Donnelly JP, Meis JF, De Keizer MH, De Pauw BE (2000) Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation. Clin Diagn Lab Immunol 7(6):889–892. https://doi.org/10.1128/cdli.7.6.889-892.2000
Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K (1997) Procalcitonin—a new indicator of the systemic response to severe infections. Infection 25(6):329–34. https://doi.org/10.1007/BF01740811
Reinhart K, Bauer M, Riedemann NC, Hartog CS (2012) New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev 25(4):609–634. https://doi.org/10.1128/CMR.00016-12
Bateman Brian T, Schmidt Ulrich, Berman Mitchell F, Bittner Edward A (2010) Temporal trends in the epidemiology of severe postoperative sepsis after elective surgery a large nationwide sample. Anesthesiology 112:917–925. https://doi.org/10.1097/ALN.0b013e3181cea3d0
Sugita S, Ogawa M, Shimizu N, Morio T, Ohguro N, Nakai K et al (2013) Use of a comprehensive polymerase chain reaction system for diagnosis of ocular infectious diseases. Ophthalmology 120:1761–1768
Sugita S, Shimizu N, Watanabe K, Katayama M, Horie S, Ogawa M et al (2011) Diagnosis of bacterial endophthalmitis by broad-range quantitative PCR. Br J Ophthalmol 95:345–349
Brodská H, Malíčková K, Adámková V, Benáková H, Šťastná MM, Zima T (2013) Significantly higher procalcitonin levels could differentiate gram-negative sepsis from gram-positive and fungal sepsis. Clin Exp Med 13(3):165–170. https://doi.org/10.1007/s10238-012-0191-8
Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22(2):240–273. https://doi.org/10.1128/CMR.00046-08
Hatzistilianou M (2010) Diagnostic and prognostic role of procalcitonin in infections. Sci World J 10:1941–1946. https://doi.org/10.1100/tsw.2010.181
Charles PE, Ladoire S, Aho S, Quenot JP, Doise JM, Prin S et al (2008) Serum procalcitonin elevation in critically ill patients at the onset of bacteraemia caused by either Gram negative or Gram-positive bacteria. BMC Infect Dis 26(8):38. https://doi.org/10.1186/1471-2334-8-38
Grace E, Turner RM (2014) Use of procalcitonin in patients with various degrees of chronic kidney disease including renal replacement therapy. Clin Infect Dis 59(12):1761–1767. https://doi.org/10.1093/cid/ciu732
Leli C, Ferranti M, Moretti A, Al Dhahab ZS, Cenci E, Mencacci A (2015) Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections. Dis Markers. https://doi.org/10.1155/2015/701480
Oussalah A, Ferrand J, Filhine-Tresarrieu P, Aissa N, Aimone-Gastin I, Namour F et al (2015) Diagnostic accuracy of procalcitonin for predicting blood culture results in patients with suspected bloodstream infection: an observational study of 35,343 consecutive patients (A STROBE-Compliant Article). Medicine (Baltimore) 94(44):e1774. https://doi.org/10.1097/MD.0000000000001774
Kocazeybek B, Küçükoğlu S, Oner YA (2003) Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis. Chemotherapy 49(1–2):76–84. https://doi.org/10.1159/000069777
Koivula I, Hämäläinen S, Jantunen E, Pulkki K, Kuittinen T, Nousiainen T et al (2011) Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia. Scand J Infect Dis 43(6–7):471–478. https://doi.org/10.3109/00365548.2011.554855
Nakajima A, Yazawa J, Sugiki D, Mizuguchi M, Sagara H, Fujisiro M et al (2014) Clinical utility of procalcitonin as a marker of sepsis: a potential predictor of causative pathogens. Intern Med 53(14):1497–1503. https://doi.org/10.2169/internalmedicine.53.1785
Acknowledgements
Hyderabad Eye Research Foundation, Hyderabad
Funding
This work was supported by Hyderabad Eye Research Foundation, Hyderabad.
Author information
Authors and Affiliations
Contributions
Conceptualisation of the project, V.P.D.; J.J.; methodology, P.N., and S.G.; software, A.M.; validation, J.J.; formal analysis, P.N.; investigation and Data curation, P.N. and S.G.; resources, TD.; and J.J.; writing—original draft preparation, P.N.; writing—review and editing, V.P.D.; J.J.; and T.D.; supervision and project administration, J.J.; and V.P.D.; funding acquisition, TD.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declared that there is no conflict of interest.
Ethical approval
This study was approved by the Institutional Review Board (Ref No. LEC 12–19-371). All procedures were performed according to the principles of the Declaration of Helsinki. A written informed consent was obtained from all study subjects.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Naik, P., Satyashree, G., Mohamed, A. et al. Evaluation of vitreous Procalcitonin as a diagnostic biomarker in infectious endophthalmitis. Int Ophthalmol 41, 3401–3409 (2021). https://doi.org/10.1007/s10792-021-01903-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-021-01903-0